View the latest Preliminary Program

Program Highlight: Plenary Session 4 – Cell Therapy and Tissue Engineering II

Amit Patel Head Shot Chair: Amit Patel, MD, MS, University of Utah, United States









Update in Cardiac Biological Therapies
Amit Patel,
MD, MS, University of Utah, United States

  • Understand the issues with first generation biologics
  • Identify positive studies for cardiovascular biologics
  • Identify patients for clinical trials

Injectable extracellular matrix hydrogels for regenerative medicine
Karen Christman, PhD, FAHA, University of California San Diego, United States

  • Learn about the state of the art in injectable biomaterials for treating myocardial infarction and peripheral artery disease
  • Learn about injectable decellularized extracellular matrix materials
  • Learn about cell delivery using injectable biomaterials

Preclinical Testing of Cell Therapy for Skeletal Muscle Dysfunction
Tracy Criswell
, PhD, Wake Forest Institute for Regenerative Medicine, United States

  • Preclinical small animal models of skeletal muscle dysfunction, useful for testing cell therapy will be discussed, with a concentration on a model of acute muscle injury used predominantly by our group.
  • The types of cells used for therapy will be discussed, including allogeneic muscle progenitor cells and a xenogeneic model using human muscle progenitor cells.
  • Biological and pharmacological factors that can be used in conjunction with cell therapy will be discussed with a primary concentration on growth factors that can be used to modify the local microenvironment of the damaged tissue in order to increase transplanted cell survival and integration.

View all the ISCT North America 2016 Regional Meeting Plenary Sessions.